So its already treating human in China and difficulty to commercialise over there, so coming here to Australia because its easier? Hmm interesting…
Market cap $152M undiluted with no IP, cancer distribution right in Australia & New Zealand only, tested on a few mice….Hmm.. I wish you well with your investment.
Ann: Complete Regression of TNBC Tumours and Protective Immunity, page-140
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
-0.005(3.85%) |
Mkt cap ! $11.01M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.5¢ | $7.206K | 57.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 77400 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 73205 | 1 |
View Market Depth
| Last trade - 10.18am 24/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |